Form 4: DHC CEO Christopher Bilotto Receives Equity Award

Diversified Healthcare Trust President and CEO Christopher J. Bilotto acquired 12,401 common shares via an equity compensation plan.

Summary

• Christopher J. Bilotto, President and CEO of Diversified Healthcare Trust (DHC), was granted 12,401 common shares on June 10, 2026.
• The transaction was executed pursuant to the issuer's equity compensation plan.
• Following this transaction, Mr. Bilotto's total beneficial ownership increased to 279,246.802 shares.
• The total includes 560.894 shares acquired through a dividend reinvestment plan since the previous filing.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding executive compensation.

Positives

• Alignment of executive interests with shareholders through increased equity ownership.
• Reflects standard executive compensation practices.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

Not applicable as this is a routine insider transaction filing.

Industry Context

StockSavvy.ai notes that routine equity grants to executive leadership are standard corporate governance practices intended to incentivize long-term performance and align management with shareholder interests.

Comparison to Industry Standards

• The transaction follows standard SEC reporting requirements for executive compensation.
• The use of equity compensation plans is consistent with industry norms for REITs and healthcare-focused investment trusts.

Stakeholder Impact

• Increased alignment between the CEO and shareholders.

Next Steps

• None specified.

Key Dates

Keywords

DHC, Diversified Healthcare Trust, Insider Trading, Form 4, Equity Compensation, Christopher Bilotto